Cullinan Therapeutics Inc (CGEM)
15.30
-0.49
(-3.10%)
USD |
NASDAQ |
Nov 14, 16:00
15.31
+0.01
(+0.07%)
After-Hours: 16:36
Cullinan Therapeutics Total Assets (Quarterly): 681.22M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 681.22M |
| March 31, 2024 | 449.43M |
| December 31, 2023 | 484.18M |
| September 30, 2023 | 494.71M |
| June 30, 2023 | 521.98M |
| March 31, 2023 | 514.99M |
| December 31, 2022 | 561.12M |
| September 30, 2022 | 617.24M |
| June 30, 2022 | 667.25M |
| Date | Value |
|---|---|
| March 31, 2022 | 437.46M |
| December 31, 2021 | 437.18M |
| September 30, 2021 | 453.40M |
| June 30, 2021 | 464.35M |
| March 31, 2021 | 479.67M |
| December 31, 2020 | 214.71M |
| September 30, 2020 | 222.02M |
| December 31, 2019 | 100.46M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
100.46M
Minimum
Dec 2019
681.22M
Maximum
Jun 2024
458.90M
Average
479.67M
Median
Mar 2021
Total Assets (Quarterly) Benchmarks
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Protalix BioTherapeutics Inc | 91.54M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 25.00M |
| Shareholders Equity (Quarterly) | 656.22M |